Alprazolam Oral Tablets (Immediate-Release)
Form: Oral tablets (immediate-release)
Strength: 0.25 mg, 0.5 mg, 1 mg, 2 mg
Reference Brands: Xanax®(US & EU), Niravam®, Alprazolam Intensol®
Category: Antipsychotropic Drugs
Alprazolam immediate-release tablets are FDA-approved in the USA for managing anxiety disorders and short-term relief of anxiety symptoms. They are also used in treating panic disorders, often as part of a broader therapeutic plan. Classified as a Schedule IV controlled substance, Alprazolam is subject to prescription-only access due to its dependence risk. In the EU, it is approved under national procedures with similar indications, governed by stringent pharmacovigilance and controlled substance regulations. Regulatory oversight ensures appropriate prescribing and monitoring. For additional forms, global suppliers, and sourcing solutions, explore Pharmatradz.com, your partner in pharmaceutical B2B procurement.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details
Zuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details
Zuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details